Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

These 5 NASDAQ Stocks Just Hit Their 52-Week Highs

Equities have seen a pullback amid uncertainty regarding the Federal Reserve’s plans to hike the interest rates. More specifically, the NASDAQ Composite Index has seen drop from its record highs registered earlier in the month. Nevertheless, some stocks from the NASDAQ Index that continued their bull run and hit a 52-week high on Monday.

In this article, we will take a look at some of these stocks, which include Finisar Corporation (NASDAQ:FNSR), Fulton Financial Corp. (NASDAQ:FULT), Itron Inc. (NASDAQ:ITRI), NetEase Inc. (ADR) (NASDAQ:NTES), and Seattle Genetics Inc. (NASDAQ:SGEN).

At Insider Monkey, we track around 740 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,


Finisar Corporation (NASDAQ:FNSR) rose to a 52-week high of $27.50 on Monday. The stock has been gaining momentum since last week, when Finisar reported its financial results for the fiscal 2017 first quarter, ended July 31. For the quarter, the company posted revenue of $341.3 million, up by 7.1% on a year-over-year basis, which topped the estimates by $8.50 million, while earnings of $0.38 per share were higher than the expected $0.30. The company also saw an improvement in its gross margins, which expanded to 31.7% from 28.4% a year ago. Out of the 749 funds in our database, 21 had a long position in Finisar at the end of June, down from 27 funds a quarter earlier. However, the total value of these funds’ positions advanced to $308.70 million, representing 16.40% of Finisar’s outstanding shares, from $302.35 million registered as of the end of March.

Follow Finisar Corp (NASDAQ:FNSR)
Trade (NASDAQ:FNSR) Now!

Fulton Financial Corp. (NASDAQ:FULT) has hit a 52-week high of $14.63, which put its year-to-date return at around 11%, outperforming the NASDAQ Index, which has inched up by 3% in the same period. Fulton’s shares have been holding steady most of the year, even though the financial sector faces uncertainties due to the Fed’s actions. A rate hike of course would be positive for banks such as Fulton as it will boost their net interest margins. That is possibly the reason why the stock has been gaining momentum over the last few days. The number of funds from our database holding shares of Fulton Financial at the end of the June quarter stood at eight, unchanged over the quarter.

Follow Fulton Financial Corp (NASDAQ:FULT)
Trade (NASDAQ:FULT) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.